Navigation Links
Omni Bio Pharmaceutical Intends to Expand Type 1 Diabetes Trial to 50 Patients
Date:2/28/2011

upon receipt of required regulatory approval and adequate financing.

Dr. Charles Dinarello, Omni Bio's Director of Medical Affairs and Chief Scientific Officer commented, "Whereas we are well into the infusion stage on our first human clinical trial of Alpha-1 antitrypsin ("AAT") in Type 1 diabetes, it is essential that we establish the foundation for pursuing the commercialization of other significant areas of our intellectual property.  Over the past six months, we have initiated discussions and provided data to leading researchers and international investigators related to our intellectual property, and are pleased to advise our shareholders that we are planning substantive programs to investigate and prove AAT's effectiveness in treating additional disease classifications."  Dr. Crapo further added, "Dr. Dinarello's own work and that of his collaborators in the fields of transplantation and GVHD are widely recognized and offer Omni Bio potential new and large markets for AAT alternative use.  While in Europe over the past several months, Charles has devoted considerable time in building key strategic relationships for Omni Bio with internationally-renowned scientists."

There is no assurance that the letters of intent will lead to the commencement of actual trials or that Omni Bio will receive regulatory approvals or be able to raise additional capital on acceptable terms or at all.

Letters of intent for human clinical trials

  • The treatment of Graft vs. Host Disease in bone marrow transplant patients.  Proposed Trial Site:  University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan.  Principal Investigator:  Pavan Reddy, MD, Associate Professor of Internal Medicine, Co-Director, BMT Leukemia/Lymphoma.
  • Two separate human clinical trials for the treatment of transplant rejection in kidney transplant recipients.  Proposed Trial Site:  Radboud University, Nijmegen M
    '/>"/>

  • SOURCE Omni Bio Pharmaceutical, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... 2014  Hologic, Inc. (NASDAQ: HOLX ), ... and Chief Executive Officer, will preside over the NASDAQ ... first day of Breast Cancer Awareness Month. In his ... on the important benefits of Hologic,s 3D Mammography technology, ... clinically superior to traditional mammography. This is ...
    (Date:9/30/2014)... 30, 2014  Tasly Pharmaceuticals, Inc., the world,s ... announced today the launch of Deepure. ... address men and women concerned with supporting their ... old age while helping keep their health care ... and herb-based formulas, namely, ProHeart PLUS, ImmunoPower PLUS, ...
    (Date:9/30/2014)... 2014 STUDY OBJECTIVES The objective ... provide an overview of the current and future ... The key objective is to present a comprehensive ... an important tool in the treatment of various ... strategies within the protein therapeutics market, which includes ...
    Breaking Medicine Technology:Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 2Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 3Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies 4
    (Date:10/1/2014)... 2014 October is national Breast Cancer ... detection plans while raising money for breast cancer research. ... Awareness Month in the effort to find a ... the importance of having access to clean, healthy water. ... linked to certain forms of cancer. , The ...
    (Date:10/1/2014)... October 01, 2014 Dr. Saj Jivraj, ... and prosthodontists, is traveling to Chennai, India, tomorrow to ... Oct. 2 and 3. , Dr. Jivraj is founder ... and Oxnard, Calif., and one of the world’s foremost ... and replacement. He is speaking to the Indian Society ...
    (Date:10/1/2014)... 01, 2014 Two bicyclists began a ... across the country in an effort to raise funds ... The cyclists, a father-daughter team, plan to bike ... Blaine, Washington and finishing in Key West Florida. ... The Warriors®, a national nonprofit organization that assists post-9/11 ...
    (Date:10/1/2014)... Tiburon, CA (PRWEB) October 01, 2014 ... find the right chamber of commerce to join, Living ... Rafael Chamber of Commerce in Marin County, the home ... demanding enough at the moment, and the thought of ... unbearable, they decided to keep looking for the right ...
    (Date:10/1/2014)... October 01, 2014 This October, Request ... consumer lab testing, is offering 10% off all testing ... when placing their order to save. The Center for ... United States are affected by Diabetes. Because many people ... go undiagnosed until it causes serious health problems. Blood ...
    Breaking Medicine News(10 mins):Health News:Pelican Water Supports Breast Cancer Awareness Month with Order Donations 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 2Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 3Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 4Health News:One of Woodland Hills’ Top Cosmetic Dentists Speaking to Indian Society of Oral Implantologists Tomorrow 5Health News:Father-Daughter Cycling Duo to Ride Cross-Country to Benefit Hope For The Warriors 2Health News:Living Well Joins San Rafael Chamber of Commerce 2Health News:Living Well Joins San Rafael Chamber of Commerce 3Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 2Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 3
    ... Promote Breast Cancer Awareness, LOS ANGELES, Sept. 27 ... Susan G. Komen for the Cure to manufacture and ... features the pink breast,cancer awareness ribbon. The pink crock ... Awareness Month and the program will,continue for six months, ...
    ... Ten Best Practices Offered to Overcome ,Pandemic Fatigue, ... issued,today by Marsh and The Albright Group, two of ... of a long-lasting pandemic are,not only likely to happen, ... pandemic is likely to exceed what most corporate and ...
    ... Kensey Nash Corporation,(Nasdaq: KNSY ) today ... and its affiliates on August 30, 2007 of ... stock, as reported by Ramius in filings with,the ... Company,s equity,compensation plan. As a result, all outstanding ...
    ... Scientific,s Market-leading Portfolio of ... Information Solutions, STAMFORD, Conn., Sept. 27 The ... provider of information,solutions to business and professional customers worldwide, ... leader in the provision of,life sciences information solutions. Prous ...
    ... Speaker Nancy Pelosi,issued the following statement on the vote ... Leave for Military Families:, "No group of Americans ... who have served in the Armed Forces. How we ... national character., "The 110th Congress is keeping faith ...
    ... Aims to Help States, Uninsured Children by Increasing Tobacco, ... Presidential Veto Looms, CHICAGO, Sept. 26 /PRNewswire/USNewswire/ -- ... across the nation facing the same problem as a,growing ... Children,s,Health Insurance Program (SCHIP) expires on September 30th; exposing,children ...
    Cached Medicine News:Health News:Susan G. Komen for the Cure Partners With the Original Butter Bell(R) Crock Developer 2Health News:New Report Says a Pandemic is Overdue, But Companies and Nations are ill Prepared to Cope With the Impact 2Health News:New Report Says a Pandemic is Overdue, But Companies and Nations are ill Prepared to Cope With the Impact 3Health News:New Report Says a Pandemic is Overdue, But Companies and Nations are ill Prepared to Cope With the Impact 4Health News:New Report Says a Pandemic is Overdue, But Companies and Nations are ill Prepared to Cope With the Impact 5Health News:Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares 2Health News:Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares 3Health News:Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares 4Health News:Thomson Acquires Prous Science 2Health News:Thomson Acquires Prous Science 3Health News:Thomson Acquires Prous Science 4Health News:Illinois AARP Presses for Expansion of Children's Health Insurance Program (SCHIP) 2
    ... recognized as an important intestinal pathogen ... parasitological techniques fail to demonstrate this ... prove effective in staining this organism. ... organisms on each slide. Each package ...
    PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
    PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
    Each slide contains a gram positive control of Staphylococcus aureus ATCC ® 25923 and a gram negative control of Escherichia coli ATCC ® 25922....
    Medicine Products: